Tango Therapeutics, Inc.
TNGX
$10.08
-$0.34-3.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 152.81M | 180.79M | 216.72M | 257.92M | 293.28M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.54M | 8.89M | 7.78M | 8.43M | 7.54M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 428.00K | 428.00K | 428.00K | -- | -- |
| Total Current Assets | 163.78M | 190.10M | 224.93M | 266.34M | 300.82M |
|
|
|||||
| Total Current Assets | 163.78M | 190.10M | 224.93M | 266.34M | 300.82M |
| Net Property, Plant & Equipment | 43.93M | 45.34M | 47.24M | 47.58M | 49.02M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.43M | 2.45M | 2.14M | 2.57M | 2.58M |
| Total Assets | 210.14M | 237.89M | 274.31M | 316.49M | 352.42M |
|
|
|||||
| Total Accounts Payable | 2.23M | 2.61M | 3.24M | 1.60M | 4.11M |
| Total Accrued Expenses | 11.38M | 9.51M | 8.40M | 14.76M | 12.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.10M | 2.53M | 2.82M | 2.45M | 2.86M |
| Total Finance Division Other Current Liabilities | 1.73M | 25.37M | 21.46M | 19.35M | 18.35M |
| Total Other Current Liabilities | 1.73M | 25.37M | 21.46M | 19.35M | 18.35M |
| Total Current Liabilities | 18.44M | 40.03M | 35.92M | 38.17M | 37.58M |
|
|
|||||
| Total Current Liabilities | 18.44M | 40.03M | 35.92M | 38.17M | 37.58M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 31.66M | 32.47M | 34.12M | 34.04M | 34.76M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 30.44M | 37.51M | 44.77M | 50.90M |
| Total Liabilities | 50.11M | 102.94M | 107.55M | 116.98M | 123.25M |
|
|
|||||
| Common Stock & APIC | 724.31M | 715.15M | 708.00M | 700.74M | 692.31M |
| Retained Earnings | -564.40M | -580.29M | -541.43M | -501.56M | -463.89M |
| Treasury Stock & Other | 121.00K | 94.00K | 194.00K | 336.00K | 750.00K |
| Total Common Equity | 160.03M | 134.95M | 166.76M | 199.52M | 229.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 160.03M | 134.95M | 166.76M | 199.52M | 229.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 160.03M | 134.95M | 166.76M | 199.52M | 229.17M |
|
|
|||||